Store by WRKOUT, the revolutionary platform that empowers wellness professionals to recommend products to their clients while…
Category: Trending
Perspire Sauna Studio Strengthens Southern Ties with First Signed Agreement In NOLA
New Orleans is soon to become home to Louisiana’s very first Perspire Sauna Studio, a premier infrared and red light…
AlphaBiolabs: Leading testing laboratory launches the most powerful DNA relationship test available
Leading testing laboratory AlphaBiolabs has just launched the most powerful DNA relationship test available. This provides customers with…
Synthego Bridges Critical Preclinical Gap to Accelerate CRISPR-based Cell and Gene Therapies
Synthego, a leading provider of genome engineering solutions, today announced the launch of its IND-enabling (INDe) gRNAs,…
IVF Disposables Market to grow by USD 248.53 million from 2022 to 2027 | North America to account for 38% of market growth- Technavio
The IVF disposables market is expected to grow by USD 248.53 million from 2022 to 2027. In addition, the momentum…
FDA Takes Action on Updated mRNA COVID-19 Vaccines to Better Protect Against Currently Circulating Variants
Today, the U.S. Food and Drug Administration took action approving and authorizing for emergency use updated…
Massage Heights Grows Canadian Footprint with Grand Opening in Alberta
Massage Heights, a leading massage and wellness franchise, announces further expansion into the Canadian market with…
Final Hours to Transform Your Life: Grab This Groundbreaking Best Seller ‘Heal Your Back Pain’ Now (08/18/23)
Dr. Fred’s groundbreaking book emerges as a beacon of hope for all those ensnared by the…
Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan
Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that the first patient has…
Iveric Bio Receives U.S. FDA Approval for IZERVAY™ (avacincaptad pegol intravitreal solution), a New Treatment for Geographic Atrophy
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”), today announced the U.S. Food and…